Literature DB >> 2181527

Transforming growth factor-beta 1 expression in irradiated liver.

M S Anscher1, I R Crocker, R L Jirtle.   

Abstract

The expression of transforming growth factor-beta 1 (TGF-beta 1) in the liver of irradiated rats was increased in a dose-dependent fashion 9 months after irradiation. Expression of TGF-beta 1 was confined primarily to hepatocytes in the pericentral region of the liver, and the percentage of hepatocytes strongly positive for TGF-beta 1 was significantly correlated with the extent of fibrosis. We further showed that a localized injection of TGF-beta 1 into normal rat liver elicited a strong fibrotic reaction at the injection site. These results suggest that the increased hepatic concentration of TGF-beta 1 in response to radiation injury may be important in the pathogenesis of radiation hepatitis. TGF-beta 1 was also found to be present at a significantly higher concentration in unirradiated human hepatocytes than in normal rat hepatocytes, implying that the propensity for humans to develop radiation hepatitis may result in part from the elevated levels of TGF-beta 1 normally found in human liver.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2181527

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  36 in total

Review 1.  Hepatic radiation toxicity: avoidance and amelioration.

Authors:  Chandan Guha; Brian D Kavanagh
Journal:  Semin Radiat Oncol       Date:  2011-10       Impact factor: 5.934

Review 2.  Radiation-associated liver injury.

Authors:  Charlie C Pan; Brian D Kavanagh; Laura A Dawson; X Allen Li; Shiva K Das; Moyed Miften; Randall K Ten Haken
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

3.  Effect of irradiation on transforming growth factor-beta secretion by malignant glioma cells.

Authors:  E Satoh; H Naganuma; A Sasaki; M Nagasaka; H Ogata; H Nukui
Journal:  J Neurooncol       Date:  1997-07       Impact factor: 4.130

Review 4.  Radiosensitizers in pancreatic cancer--preclinical and clinical exploits with molecularly targeted agents.

Authors:  Amanda J Walker; Sara R Alcorn; Amol K Narang; Katriana M Nugent; Aaron T Wild; Joseph M Herman; Phuoc T Tran
Journal:  Curr Probl Cancer       Date:  2013-10-05       Impact factor: 3.187

5.  MiR-663 inhibits radiation-induced bystander effects by targeting TGFB1 in a feedback mode.

Authors:  Wentao Hu; Shuai Xu; Bin Yao; Mei Hong; Xin Wu; Hailong Pei; Lei Chang; Nan Ding; Xiaofei Gao; Caiyong Ye; Jufang Wang; Tom K Hei; Guangming Zhou
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

6.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions.

Authors:  N Sanderson; V Factor; P Nagy; J Kopp; P Kondaiah; L Wakefield; A B Roberts; M B Sporn; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

7.  Taurine attenuates radiation-induced lung fibrosis in C57/Bl6 fibrosis prone mice.

Authors:  W B Robb; C Condron; M Moriarty; T N Walsh; D J Bouchier-Hayes
Journal:  Ir J Med Sci       Date:  2009-07-16       Impact factor: 1.568

8.  Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy.

Authors:  Zhonghua Lu; Yiting Tang; Judong Luo; Shuyu Zhang; Xifa Zhou; Lei Fu
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

9.  Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma.

Authors:  Jeffrey M Vainshtein; Rafi Kabarriti; Keyur J Mehta; Jayanta Roy-Chowdhury; Chandan Guha
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-07-15       Impact factor: 7.038

10.  Halofuginone enhances the radiation sensitivity of human tumor cell lines.

Authors:  John A Cook; Rajani Choudhuri; William Degraff; Janet Gamson; James B Mitchell
Journal:  Cancer Lett       Date:  2009-08-26       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.